14 December 2023 - Spending on biologics in 2021 represented $260 billion or 46% of all spending on prescription drugs in ...
13 November 2023 - Median brand name drug launch prices increased from $2,115 in 2008 to $180,007 in 2021. ...
13 November 2023 - In 2021, 46% ($260 billion) of all gross prescription drug spending in the US was on biologic ...
2 October 2023 - A US Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo ...
1 August 2023 - Brand name pharmaceutical manufacturers often sustain high prices in the US by obtaining patents that delay generic ...
28 January 2023 - AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. ...
25 January 2023 - As the 118th Congress convenes this month in Washington D.C., many pundits and advocates have little ...
17 January 2023 - Medunik Canada is pleased to announce that on 9 January 2023, the Federal Court of Appeal of ...
13 January 2022 - In 2022, several bills were introduced in Congress to revamp US intellectual property law. ...
6 December 2022 - The United States on Tuesday urged delaying a decision on whether to waive patent protection for ...
4 November 2022 - The US Supreme Court on Friday agreed to hear Amgen's bid to revive patents on its ...
3 August 2022 - A U.S. appeals court on Monday affirmed that AbbVie Inc did not unlawfully block competition by ...
1 August 2022 - New drugs are protected by patents that block generic competition and allow manufacturers to charge high prices. ...
17 June 2022 - Speaking about the waiver, EFPIA Director General, Nathalie Moll said. “The decision is a serious retrograde step ...
20 June 2022 - The decision to waive intellectual property protections for COVID-19 vaccines is fundamentally flawed and will have ...